REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Essmedi (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Essmedi Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Essmedi is a company in Lithuania, with a head office in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 12, 2011. 21 (2025) employees currently work for UAB Essmedi. The company’s latest financial report indicates a net sales revenue drop of 10.51% in 2024. In, 2024, the company’s net profit margin decreased by 1.02%.

Headquarters
Didzioji g. 30
Vilnius; Vilnius county; Postal Code: LT-01128

Contact Details: Purchase the UAB Essmedi report to view the information.

Website: http://www.essmedi.com

Basic Information
Total Employees:
Purchase the UAB Essmedi report to view the information.
Registered Capital:
Purchase the UAB Essmedi report to view the information.
Financial Auditors:
Purchase the UAB Essmedi report to view the information.
Incorporation Date:
April 12, 2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Essmedi report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-10.51%
Total operating revenue
-10.51%
Net Profit (Loss) for the Period
-64.71%
Total Equity
-1.41%
Net Profit Margin
-1.02%
Return on Equity (ROE)
-6.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?